Company · CIK 0001754068 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Kalaris Therapeutics, Inc. · KLRS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 AForm 4 → | Aug 28, 4:10 pm EDT | Amy O'Leary VandekopVP, Corporate Controller | 10,000 | — | — | 10,000 | — | |
| Aug 1, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Laurie KeatingDirector | 18,000 | — | — | 18,000 | — | |
| Jul 20, 2026 AForm 4 → | Jul 20, 5:04 pm EDT | Liisa Ann BaykoChief Financial Officer | 220,000 | — | — | 220,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:38 pm EDT | Morana Jovan-EmbiricosDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:36 pm EDT | Napoleone FerraraDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:28 pm EDT | David HallalDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:25 pm EDT | Srinivas AkkarajuDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:23 pm EDT | Michael DybbsDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:22 pm EDT | Anthony P AdamisDirector | 9,000 | — | — | 9,000 | — | |
| Jun 3, 2026 AForm 4 → | Jun 4, 4:19 pm EDT | Leone D PattersonDirector | 9,000 | — | — | 9,000 | — |